| PRECLINICAL | evidence | Thymosin beta-4 is a novel regulator for primary cilium formation by nephronophthisis 3 in HeLa human cervical cancer cells. | Tbeta4 | — | 2019-05-02 |
| PRECLINICAL | evidence | Association between thymosin beta4 and non-alcoholic fatty liver disease. | Tbeta4 | — | 2019-04-01 |
| PRECLINICAL | evidence | Cellular mechanism of Tbeta4 intervention in liver fibrosis by regulating NF-kappaB signaling pathway. | Tbeta4 | Liver health | 2019-02-01 |
| PRECLINICAL | evidence | Local Thymosin beta4 Gel Injection Prevents Esophageal Stricture after Circumferential Endoscopic Submucosal Dissection in a Porcine Model. | Tbeta4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance. | Tbeta4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin. | Thymosin beta 4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Investigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior. | Thymosin beta 4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Persistent Corneal Epithelial Defects: A Review Article. | Thymosin beta 4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Adipose-Derived Mesenchymal Stem Cells Enhance Ovarian Cancer Growth and Metastasis by Increasing Thymosin Beta 4X-Linked Expression. | Thymosin beta 4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 prevents oxygen-glucose deprivation/reperfusion-induced injury in rat cortical neurons. | Tbeta4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 Regulates Focal Adhesion Formation in Human Melanoma Cells and Affects Their Migration and Invasion. | Tbeta4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application. | Tbeta4 | — | 2019-01-01 |
| PRECLINICAL | evidence | Correction: Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4. | Thymosin beta 4 | — | 2018-12-25 |
| PRECLINICAL | evidence | Rapid Detection and Identification of Antimicrobial Peptide Fingerprints of Nasal Fluid by Mesoporous Silica Particles and MALDI-TOF/TOF Mass Spectrometry: From the Analytical Approach to the Diagnostic Applicability in Precision Medicine. | Thymosin β4 | — | 2018-12-12 |
| PRECLINICAL | evidence | Quantification of protein markers monitoring the pre-analytical effect of blood storage time before plasma isolation using (15) N metabolically labeled recombinant proteins. | Thymosin beta 4 | — | 2018-12-01 |
| PRECLINICAL | evidence | Synthesis and Biological Activity of Thymosin beta4-Anionic Boron Cluster Conjugates. | Tbeta4 | preclinical | 2018-11-21 |
| PRECLINICAL | evidence | Thymosin beta4 is associated with bone sialoprotein expression via ERK and Smad3 signaling pathways in MDPC-23 odontoblastic cells. | Tbeta4 | — | 2018-11-01 |
| PRECLINICAL | evidence | Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study. | Thymosin β4 | Skin appearance & aging | 2018-10-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes glucose-impaired endothelial progenitor cell function via Akt/endothelial nitric oxide synthesis signaling pathway. | Tbeta4 | — | 2018-10-01 |
| PRECLINICAL | evidence | Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis. | Tbeta4 | — | 2018-09-20 |
| PRECLINICAL | evidence | Crybb2 associates with Tmsb4X and is crucial for dendrite morphogenesis. | Thymosin beta 4 | — | 2018-09-03 |
| PRECLINICAL | evidence | Thymosin beta4 suppresses CCl(4) -induced murine hepatic fibrosis by down-regulating transforming growth factor beta receptor-II. | Tbeta4 | Liver health | 2018-09-01 |
| PRECLINICAL | evidence | Inhibition of acetaminophen-induced hepatotoxicity in mice by exogenous thymosinbeta4 treatment. | Tbeta4 | — | 2018-08-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes endothelial progenitor cell angiogenesis via a vascular endothelial growth factor‑dependent mechanism. | Tbeta4 | Wound healing | 2018-08-01 |
| PRECLINICAL | evidence | The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases. | Tbeta4 | Lipid & cardiovascular markers | 2018-08-01 |
| PRECLINICAL | evidence | Induced pluripotent stem cell derived cardiac models: effects of Thymosin beta4. | Tbeta4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta4 for the treatment of acute stroke: neurorestorative or neuroprotective? | Tbeta4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations. | Thymosin beta 4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta4 for the treatment of acute stroke: neurorestorative or neuroprotective? | TB4 | Neuroprotection | 2018-07-01 |
| PRECLINICAL | evidence | Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations. | TB4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta 4 regulation of actin in sepsis. | Thymosin beta 4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review). | Thymosin beta 4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin-beta4: A key modifier of renal disease. | Thymosin beta 4 | Inflammation | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain. | Tbeta4 | Liver health | 2018-07-01 |
| PRECLINICAL | evidence | The role of Thymosin beta4 in angiotensin II-induced cardiomyocytes growth. | Tbeta4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta4 limits inflammation through autophagy. | Tbeta4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta4 and the vasculature: multiple roles in development, repair and protection against disease. | Tbeta4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Anti-inflammatory potential of thymosin beta4 in the central nervous system: implications for progressive neurodegenerative diseases. | Tbeta4 | Inflammation | 2018-07-01 |
| PRECLINICAL | evidence | Induced pluripotent stem cell derived cardiac models: effects of Thymosin beta4. | TB4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta 4 and the eye: the journey from bench to bedside. | Tbeta4 | Wound healing | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin beta4-mediated protective effects in the heart. | Tbeta4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Thymosin fraction 5 re-evaluated after 35 years by high-resolution mass spectrometry. | Thymosin beta 4 | — | 2018-07-01 |
| PRECLINICAL | evidence | Potential mechanism of thymosin-alpha1-membrane interactions leading to pleiotropy: experimental evidence and hypotheses. | Thymosin β4 | — | 2018-07-01 |
| PRECLINICAL | evidence | A dimeric thymosin beta 4 with novel bio-activity protects post-ischemic cardiac function by accelerating vascular endothelial cell proliferation. | Tbeta4 | — | 2018-06-15 |
| PRECLINICAL | evidence | A self-organized actomyosin drives multiple intercellular junction disruption and directly promotes neutrophil recruitment in lipopolysaccharide-induced acute lung injury. | Thymosin β4 | — | 2018-06-07 |
| PRECLINICAL | evidence | No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart. | Thymosin beta 4 | — | 2018-06-01 |
| PRECLINICAL | evidence | No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart. | TB4 | — | 2018-06-01 |
| PRECLINICAL | evidence | Effect of vitamin A deficiency on thymosin-beta4 and CD4 concentrations. | Tbeta4 | — | 2018-06-01 |
| PRECLINICAL | evidence | Chimeric Adeno-Associated Virus-Mediated Cardiovascular Reprogramming for Ischemic Heart Disease. | Tbeta4 | — | 2018-05-31 |
| PRECLINICAL | evidence | Tumor Progression Is Mediated by Thymosin-beta4 through a TGFbeta/MRTF Signaling Axis. | Tbeta4 | — | 2018-05-01 |